查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1885941

全球生育治療服務市場

Fertility Services
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球生育服務市場預計2030年將達到1,242億美元。

全球生育治療服務市場規模預計在2024年為538億美元，到2030年將達到1,242億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為15.0%。本報告分析的細分市場之一——「新鮮非捐精」市場——預計將以16.1%的複合年成長率成長，並在分析期結束時達到753億美元。同時，「冷凍非捐精」市場預計在分析期間內將以13.7%的複合年成長率成長。

美國市場規模估計為136億美元，而中國市場預計將以19.4%的複合年成長率成長。

據估計，2024年美國不孕症治療服務市場規模將達136億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到317億美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）將達到19.4%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期內，兩國的複合年成長率將分別達到10.1%和12.5%。在歐洲，德國的複合年成長率預計將達到約11.3%。

全球生育服務市場—主要趨勢與促進因素概述

生育服務如何改變生殖健康與家庭計畫？

生育服務透過為面臨生育難題的個人和夫婦提供先進的醫療干預和個人化護理，正在改變生殖健康和計劃生育的面貌。隨著人們對生育治療的認知和接受度不斷提高，輔助生殖技術（ART）的進步，例如體外受精（IVF）、卵子冷凍和基因篩檢，正為全球數百萬人帶來希望。生育服務涵蓋多種治療方法，旨在診斷和治療不孕症、協助計劃生育以及改善生殖健康。這些服務正成為現代醫學的重要組成部分，使個人和夫婦無論年齡、健康狀況或其他因素如何，都能實現為人父母的夢想。

近年來，生育年齡延遲、生活方式改變以及不孕症上升等社會變遷導致人們對生育治療服務的需求日益成長。如今，生育診所提供的服務範圍廣泛，涵蓋不孕症評估、荷爾蒙治療以及尖端輔助生殖技術（ART）。冷凍卵子已成為一種顯著趨勢，尤其是在希望保存生育能力以備將來懷孕的女性中。生育治療服務的擴展不僅賦予個人掌控自身生殖健康的能力，也使計劃生育更加便利和包容，尤其惠及同性伴侶、單親父母以及面臨生殖健康挑戰的人。隨著生育治療技術的進步和社會接受度的提高，這些服務正在深刻地改變人們的計劃生育方式。

為什麼生育服務對於解決生殖挑戰和擴大計劃生育選擇至關重要？

生育服務對於解決生育難題和拓展計劃生育選擇至關重要，因為它為難以自然受孕的個人和夫婦提供了醫療解決方案。全球約有10-15%的夫婦受到不孕症的困擾，生育服務透過診斷和治療導致不孕的根本原因，為他們帶來希望和支持。雖然不孕症的原因有很多，包括老齡化、荷爾蒙失衡、遺傳因素和生活方式問題，但整個過程在身心上都可能令人疲憊不堪。體外受精（IVF）、人工授精（IUI）以及卵子和精子捐贈等生育治療方法可以幫助克服這些障礙，並實現懷孕。

對於那些並非面臨不孕不育，而是尋求家庭計畫的人來說，生育服務同樣至關重要。卵子冷凍技術可以幫助那些因個人或職業原因選擇推遲生育的女性，使她們能夠在最佳時機儲存卵子，並為未來的懷孕計畫提供更大的靈活性。此外，生育服務也為LGBTQ+群體、伴侶和單親父母提供了重要的選擇。無論您需要卵子捐贈、精子捐贈或代孕來建立家庭，這些服務都能讓您擁有更包容和多元化的育兒途徑，擺脫生物學或傳統家庭結構對父母權利的限制。

生育服務的另一個重要作用是解決卵巢症候群（PCOS）、子宮內膜異位症和男性不孕症（包括精子數量少和活力低）等問題。雖然這些疾病常常未被診斷和治療，但生育診所提供針對性的治療和介入措施，以提高受孕幾率。此外，基因篩檢和胚胎著床前遺傳學檢測（PGT）技術的進步使得在受孕前識別遺傳疾病成為可能，從而確保父母和嬰兒的健康。這種全面的生育治療方法正在幫助更多人應對複雜的生育挑戰，並以前所未有的方式擴展他們的家庭選擇。

生殖醫學領域不孕症治療服務的應用與創新有哪些擴展與創新？

在醫療技術、遺傳學和個人化生殖醫學的推動下，生育治療服務的範圍和創新正在迅速擴展。其中一個最重要的進展是體外受精（IVF）的廣泛應用，它徹底改變了夫妻和個人應對不孕症的方式。體外受精是指在體外使卵子受精，然後將形成的胚胎移植到子宮內。隨著技術的進步，體外受精的成功率不斷提高，使其成為不孕症最有效的治療方法方法之一。延時成像和胚胎監測系統等創新技術使胚胎學家能夠更精確地評估胚胎發育情況，從而提高胚胎著床和妊娠成功的幾率。

卵子和精子冷凍技術的顯著進步也拓展了生育力保存的機會。包括玻璃化冷凍在內的冷凍保存技術，能夠以更高的活力冷凍卵子和精子，使人們可以選擇推遲生育。這對於面臨化療不孕風險的癌症患者以及出於個人或職業原因希望保存生育能力的女性尤其重要。此外，精子採集技術的進步也為精子數量少和其他不孕問題的男性提供了解決方案，使他們能夠透過輔助生殖技術受孕。

另一項生育服務領域的突破性創新是胚胎胚胎著床前遺傳學檢測（PGT），它允許在胚胎胚胎著床前進行基因篩檢。 PGT可以檢測染色體異常和遺傳疾病，例如囊腫纖維化、鐮狀細胞貧血和亨廷頓病，確保在體外受精（IVF）過程中移植的都是健康的胚胎。這項技術不僅提高了懷孕成功率，也降低了流產風險和子女遺傳疾病的風險。遺傳諮詢現已成為生育服務不可或缺的一部分，幫助夫妻根據自身的基因組成，就生育選擇做出明智的決定。

除了這些技術進步之外，生育服務也朝著更全面的生殖健康模式發展。越來越多的診所認知到關注生育治療中情緒、生理和心理因素的重要性，因此提供諸如生育指導、營養諮詢、心理健康諮詢和針灸等支持服務。生育診所也擴大採用數位化醫療工具，遠端醫療諮詢、排卵週期追蹤應用程式和遠端監測已成為常態。這種以患者為中心的照護模式，為患者在複雜的生育過程中提供了更多支持和便利。

生育服務領域的另一項創新是人工智慧 (AI) 和機器學習的日益普及。人工智慧系統正在分析包括患者資訊、胚胎發育和治療結果在內的大規模資料集，以幫助醫生更精準地制定生育治療方案。例如，它們可以根據患者的病歷、遺傳資訊和胚胎品質預測體外受精 (IVF) 週期的成功率，從而製定更個人化和有效的治療策略。這些創新使生育治療更有效率、便利性和成功，為渴望建立家庭的個人和夫婦開闢了新的可能性。

哪些因素正在推動生育治療服務市場的成長？

推動不孕症治療服務市場成長的關鍵因素有很多，包括不孕症上升、生育年齡偏大、生殖醫學技術的進步以及社會對不孕症治療的接受度提高。其中一個主要促進因素是全球不孕症發病率的上升，這影響著男性和女性。生活方式的改變、環境污染、壓力以及肥胖和卵巢症候群（PCOS）等疾病都導致了不孕症的上升。隨著越來越多的人難以自然受孕，體外受精（IVF）、人工授精（IUI）和生育力保存等治療方法的普及，對不孕症治療服務的需求持續成長。

推動生育治療服務市場成長的另一個關鍵因素是生育年齡普遍偏大的趨勢。隨著越來越多的女性將事業、教育和個人目標置於首位，許多人選擇在晚年生育。然而，年齡是生育治療的關鍵因素，尤其對女性而言，因為生育能力會隨著老齡化的成長而下降。包括卵子冷凍和體外受精（IVF）在內的生育治療服務為希望保存生育能力並在晚年懷孕的女性提供了解決方案，從而導致對這些服務的需求不斷成長。此外，隨著再婚和重組家庭的增多，越來越多的老年人和夫婦選擇使用生育治療服務來共同生育子女，這進一步推動了市場成長。

生殖醫學技術的進步在推動生育治療服務市場的擴張中發揮關鍵作用。諸如胚胎著床前遺傳學檢測（PGT）、延時胚胎監測和冷凍保存技術等創新技術提高了生育治療的成功率，使其成為尋求輔助生殖的個人和夫婦更具吸引力的選擇。人工智慧和機器學習在生育診所的應用，透過提供更個人化的照護和最佳化治療策略，進一步改善了治療效果。這些技術進步使生育治療更加有效和便捷，鼓勵更多人考慮生育治療方案。

社會對生育治療接受度的提高也是推動市場成長的主要因素。生育治療曾一度被視為禁忌並飽受歧視，如今已廣受認可和肯定，尤其是在已開發國家。名人和公眾名流公開分享他們的生育治療經歷，有助於減少圍繞不孕症的污名，並鼓勵更多人使用生育治療服務。此外，同性婚姻法律授權、代孕和捐精等法律和社會進步，也為LGBTQ+群體和單親父母組建家庭開闢了新的途徑。隨著這些治療手段的普及和普及，生育治療服務市場持續擴張。

政府加強對不孕症治療的支持力度，並擴大醫療保險覆蓋範圍，也是推動市場成長的因素。在許多國家，保險公司和醫療系統已開始承擔部分不孕症治療費用，例如體外受精（IVF），使更多人能夠負擔得起治療費用。政府為促進生殖健康和提供不孕症治療經濟支持的舉措，也有助於提高這些服務的可近性。在出生率下降的地區，政府正將不孕症治療視為刺激人口成長國家策略的一部分進行投資，這進一步促進了市場擴張。

總而言之，隨著越來越多的個人和夫婦尋求輔助生殖技術以克服不孕症、推遲生育或選擇非傳統生育方式，生育服務市場預計將迎來顯著成長。隨著生殖技術的進步、社會接受度的提高以及生育治療的普及，該行業將在幫助人們實現為人父母的夢想方面發揮日益重要的作用。隨著生育治療技術的不斷發展，它們將提供更全面、更有效、更個人化的護理，從而徹底改變全球生殖醫學和計劃生育領域。

部分：

細分市場（新鮮非捐贈者、冷凍非捐贈者、卵子/胚胎庫、新鮮捐贈者、冷凍捐贈者）、最終用途（生育診所、醫院、手術中心、臨床研究機構）

受訪公司範例

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片文字稿、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在國、製造地以及進出口（成品和OEM產品）情況，預測企業競爭格局的變化。這種複雜多變的市場現實將對競爭對手產生多方面的影響，包括銷貨成本增加、盈利下降和供應鏈重組，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP11932

Global Fertility Services Market to Reach US$124.2 Billion by 2030

The global market for Fertility Services estimated at US$53.8 Billion in the year 2024, is expected to reach US$124.2 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2024-2030. Fresh Non-Donor, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$75.3 Billion by the end of the analysis period. Growth in the Frozen Non-Donor segment is estimated at 13.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.6 Billion While China is Forecast to Grow at 19.4% CAGR

The Fertility Services market in the U.S. is estimated at US$13.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$31.7 Billion by the year 2030 trailing a CAGR of 19.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.1% and 12.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.3% CAGR.

Global Fertility Services Market - Key Trends and Drivers Summarized

How Are Fertility Services Revolutionizing Reproductive Health and Family Planning?

Fertility services are transforming reproductive health and family planning by offering advanced medical interventions and personalized care to individuals and couples facing challenges in conceiving. With increasing awareness and acceptance of fertility treatments, advancements in assisted reproductive technologies (ART), such as in vitro fertilization (IVF), egg freezing, and genetic screening, are giving hope to millions of people worldwide. Fertility services include a range of treatments that help diagnose and treat infertility, support family planning, and improve reproductive health. These services are becoming essential in the modern landscape of healthcare, allowing individuals and couples to realize their dreams of parenthood despite age, medical conditions, or other factors.

In recent years, the demand for fertility services has grown due to societal changes, such as delayed childbearing, lifestyle factors, and rising infertility rates. Fertility clinics now offer a wide array of services, from fertility assessments and hormonal treatments to cutting-edge ART procedures. The rise of egg freezing, particularly among women who wish to preserve their fertility for future pregnancies, has become a significant trend. This expansion of fertility services is not only empowering individuals to take control of their reproductive health but is also making family planning more accessible and inclusive, especially for same-sex couples, single parents, and those facing reproductive health challenges. As fertility treatments advance and societal acceptance grows, these services are playing a transformative role in how people plan their families.

Why Are Fertility Services Critical for Addressing Reproductive Challenges and Expanding Family Planning Options?

Fertility services are critical for addressing reproductive challenges and expanding family planning options because they offer medical solutions to individuals and couples who may face obstacles in conceiving naturally. With the increasing prevalence of infertility-affecting around 10-15% of couples globally-fertility services provide hope and support by diagnosing and treating underlying conditions that hinder conception. Whether due to age, hormonal imbalances, genetic factors, or lifestyle issues, infertility can be emotionally and physically taxing. Fertility treatments such as in vitro fertilization (IVF), intrauterine insemination (IUI), and egg or sperm donation enable people to overcome these barriers and achieve successful pregnancies.

Fertility services are also crucial in providing options for those who may not face infertility but are seeking alternatives for family planning. Women who choose to delay childbearing for personal or career reasons can now turn to egg freezing, which preserves their eggs at an optimal time, giving them the flexibility to conceive later in life. Additionally, fertility services offer crucial options for LGBTQ+ individuals and couples, as well as single parents, who may require donor eggs, sperm, or surrogacy to start a family. These services ensure that parenthood is not limited by biological constraints or traditional family structures, offering more inclusive and diverse pathways to having children.

Another key role of fertility services is in addressing medical conditions like polycystic ovary syndrome (PCOS), endometriosis, and male infertility issues such as low sperm count or motility. These conditions often go undiagnosed and untreated, but fertility clinics provide targeted treatments and interventions that increase the chances of conception. Furthermore, advancements in genetic screening and preimplantation genetic testing (PGT) allow for the identification of genetic disorders before pregnancy, ensuring healthier outcomes for both parents and babies. This comprehensive approach to fertility care is helping more people navigate complex reproductive challenges and expand their family-building options in ways that were not possible before.

What Are the Expanding Applications and Innovations in Fertility Services Across Reproductive Health?

The applications and innovations in fertility services are rapidly expanding, driven by breakthroughs in medical technology, genetics, and personalized reproductive care. One of the most significant advancements in fertility services is the rise of in vitro fertilization (IVF), which has revolutionized how couples and individuals approach infertility. IVF involves the fertilization of an egg outside the body, followed by the implantation of the embryo into the uterus. As technology improves, success rates for IVF have increased, making it one of the most effective treatments for infertility. Innovations such as time-lapse imaging and embryo monitoring systems allow embryologists to assess the development of embryos with greater precision, improving the chances of successful implantation and pregnancy.

Egg and sperm freezing technologies have also seen significant improvements, providing more opportunities for fertility preservation. Cryopreservation methods, including vitrification, have made it possible to freeze eggs and sperm with higher survival rates, offering individuals the flexibility to delay parenthood. This is particularly important for cancer patients who may face fertility loss due to chemotherapy, as well as women who want to preserve their fertility for personal or professional reasons. Additionally, advancements in sperm extraction techniques have provided solutions for men with low sperm counts or other fertility issues, allowing them to conceive through assisted reproductive technologies.

Another groundbreaking innovation in fertility services is preimplantation genetic testing (PGT), which allows for the genetic screening of embryos before implantation. PGT can detect chromosomal abnormalities or genetic disorders such as cystic fibrosis, sickle cell anemia, and Huntington’s disease, ensuring that only healthy embryos are transferred during IVF. This technology not only increases the chances of a successful pregnancy but also reduces the risk of miscarriage and genetic diseases in the child. Genetic counseling is now an integral part of fertility services, allowing couples to make informed decisions about their reproductive options based on their genetic makeup.

In addition to these technological advancements, fertility services are expanding to include a more holistic approach to reproductive health. Clinics are increasingly offering support services such as fertility coaching, nutritional guidance, mental health counseling, and acupuncture, recognizing the importance of addressing the emotional, physical, and psychological aspects of fertility treatment. Fertility clinics are also embracing digital health tools, with telemedicine consultations, fertility tracking apps, and remote monitoring becoming more common. This shift toward patient-centered care is helping individuals navigate the complex fertility journey with greater support and convenience.

Another area of innovation in fertility services is the growing use of artificial intelligence (AI) and machine learning in fertility treatments. AI-powered systems are being used to analyze large datasets of patient information, embryo development, and treatment outcomes, helping doctors make more accurate decisions about fertility treatment plans. For example, AI can be used to predict the success rates of IVF cycles based on patient history, genetics, and embryo quality, allowing for more personalized and effective treatment strategies. These innovations are making fertility treatments more efficient, accessible, and successful, opening up new possibilities for individuals and couples seeking to build families.

What Factors Are Driving the Growth of the Fertility Services Market?

Several key factors are driving the growth of the fertility services market, including the rising prevalence of infertility, delayed childbearing, advancements in reproductive technologies, and increasing societal acceptance of fertility treatments. One of the primary drivers is the growing global incidence of infertility, which is affecting both men and women. Factors such as lifestyle changes, environmental pollutants, stress, and medical conditions like obesity and polycystic ovary syndrome (PCOS) are contributing to rising infertility rates. As more people face challenges in conceiving naturally, the demand for fertility services continues to rise, with treatments like IVF, IUI, and fertility preservation becoming more commonplace.

Another significant factor contributing to the growth of the fertility services market is the trend toward delayed childbearing. With more women prioritizing their careers, education, and personal goals, many are choosing to have children later in life. However, age is a critical factor in fertility, particularly for women, as fertility declines with age. Fertility services, including egg freezing and IVF, provide solutions for women who wish to preserve their fertility and conceive later in life, leading to increased demand for these services. Additionally, with the rise in second marriages and blended families, fertility services are being used by older individuals or couples who wish to have children together, further driving market growth.

Advancements in reproductive technologies are also playing a crucial role in the expansion of the fertility services market. Innovations such as preimplantation genetic testing (PGT), time-lapse embryo imaging, and cryopreservation techniques have improved the success rates of fertility treatments, making them more appealing to individuals and couples seeking reproductive assistance. The integration of AI and machine learning in fertility clinics is further enhancing treatment outcomes by providing more personalized care and optimizing treatment strategies. These technological advancements are making fertility treatments more effective and accessible, encouraging more people to explore fertility options.

The growing societal acceptance of fertility treatments is another major factor driving market growth. Fertility treatments, once considered taboo or stigmatized, are now widely accepted and embraced, especially in developed countries. Public figures and celebrities openly discussing their fertility journeys have helped to reduce the stigma around infertility, encouraging more people to seek fertility services. Moreover, legal and social advancements, such as the recognition of same-sex marriages and the availability of surrogacy and donor programs, are providing new pathways for LGBTQ+ individuals and single parents to build families. As these treatments become more accessible and normalized, the fertility services market continues to expand.

Increasing government support and healthcare coverage for fertility treatments are also driving the growth of the market. In many countries, insurance companies and healthcare systems are beginning to cover a portion of the costs associated with fertility treatments like IVF, making them more affordable for a broader population. Government initiatives that promote reproductive health and provide financial assistance for fertility treatments are also helping to increase access to these services. In regions where fertility rates are declining, governments are investing in fertility treatments as part of national efforts to boost population growth, further contributing to the expansion of the market.

In conclusion, the fertility services market is poised for significant growth as more individuals and couples seek reproductive assistance to overcome infertility, delay parenthood, or pursue non-traditional family-building options. With advancements in reproductive technologies, growing societal acceptance, and increasing access to fertility services, the industry is set to play an even larger role in helping people realize their dreams of parenthood. As fertility treatments continue to evolve and improve, they will provide more inclusive, effective, and personalized care, revolutionizing the landscape of reproductive health and family planning worldwide.

SCOPE OF STUDY:

The report analyzes the Fertility Services market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor, Frozen Donor); End-Use (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Fertility Services - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Infertility Rates Driving Demand for Fertility Services
    • Advancements in Assisted Reproductive Technologies (ART) Enhancing Success Rates
    • Growing Acceptance and Legalization of IVF and Surrogacy Across Different Regions
    • Market Trends Toward Personalized Treatment Plans Based on Genetic Testing
    • Future Directions: Integration of AI and Machine Learning in Fertility Treatment Protocols
    • Technological Innovations in Embryo Screening and Preservation Techniques
    • Global Increase in Same-Sex Couples and Single Parents Using Fertility Services
    • Regulatory and Ethical Considerations in Egg and Sperm Donation
    • Development of Mobile Apps and Online Platforms for Fertility Consultation and Management
    • Market Response to Growing Trends in Egg Freezing for Career Planning
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fertility Services Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Egg & Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Egg & Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Clinical Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030
  • AFRICA
    • Fertility Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION